Joachim TheilhaberSummaryAffiliation: Aventis Pharma Publications
| Collaborators
|
Detail Information
Publications
Finding genes in the C2C12 osteogenic pathway by k-nearest-neighbor classification of expression dataJoachim Theilhaber
Aventis Pharmaceuticals, Cambridge Genomics Center, Cambridge, Massachusetts 02139, USA
Genome Res 12:165-76. 2002..The methodology should be generalizable to any situation in which enough a priori biological knowledge exists to define a training set...
GECKO: a complete large-scale gene expression analysis platformJoachim Theilhaber
Cambridge Genomics Center, Sanofi Aventis, 26 Landsdowne Street, Cambridge, MA 02139, USA
BMC Bioinformatics 5:195. 2004..Gecko (Gene Expression: Computation and Knowledge Organization) is a complete, high-capacity centralized gene expression analysis system, developed in response to the needs of a distributed user community...
Identification of a molecular signature of sarcopeniaPaul G Giresi
Department of Health Sciences, Boston University, Boston, Massachusetts, USA
Physiol Genomics 21:253-63. 2005..The sarcopenia signature developed here will be useful as a molecular model to judge the effectiveness of exercise and other therapeutic treatments aimed at ameliorating the effects of muscle loss associated with aging...
